Zeus Capital published a note out this morning on Research Tree: "Deltex Medical Group plc (DEMG), the global leader in the field of Oesophageal Doppler Monitoring (ODM), today announced the establishment of two new platform programme accounts in the USA. Deltex has now established 7 new hospital accounts in the US this year and with 24 in total is well on the way to achieving its target of 30 in Q3 2016. One of the new accounts is with a large hospital in the San Francisco area within Deltex’s West Coast sales territory which is contracted to minimum order volumes of 30 probes per month following the initial order of 50 probes."
Zeus Capital's note out this morning on Research Tree: "Deltex Medical Group plc (DEMG), the global leader in the field of Oesophageal Doppler Monitoring (ODM), today announced excellent initial results from the largest ever randomised clinical trial (conducted in 450 patients undergoing major surgery in 5 hospitals in Spain) assessing the impact of oesophageal Doppler monitoring (ODM) on post-operative complications. As a result of these findings, presented at the Euroanaesthesia 2016 conference in London, ODM is indicated as the preferred method for intra-operative fluid manage..."
Welcome to the new Deltex Medical Group stream forum! Messages posted in the Deltex Medical Group stream will be logged here for posterity.
Latest from the Community...
Latest from the Community...
Latest from the Community...